Literature DB >> 18690289

Generation and validation of a mouse line with a floxed SRC-3/AIB1 allele for conditional knockout.

Zhaoliang Liu1, Lan Liao, Suoling Zhou, Jianming Xu.   

Abstract

The steroid receptor coactivator-3 (SRC-3), also known as AIB1, ACTR, p/CIP and NCOA3, is a transcriptional coactivator for nuclear receptors and certain other transcription factors. SRC-3 is widely expressed and plays important physiological functions and pathogenic roles in breast and prostate cancers. SRC-3 knockout (SRC-3(-/-)) mice display genetic background-dependent embryonic lethality and multiple local and systemic abnormalities. Since both the partial lethality and the systemic effects caused by global SRC-3 knockout interfere with downstream investigation of tissue-specific function of SRC-3, we have generated floxed SRC-3 (SRC-3(f/f)) mice with conditional alleles carrying loxP sites in introns 10 and 12 by a gene-targeting strategy. The two SRC-3(f/f) mouse lines (A and B) are indistinguishable from wild type mice. To test if deletion of the floxed exons 11 and 12 for SRC-3 nuclear receptor interaction domains and disruption of its downstream sequence for transcriptional activation domains would inactivate SRC-3 function, SRC-3(f/f) mice were crossbred with EIIa-Cre mice to generate SRC-3(d/d) mice with germ line deletion of the floxed SRC-3 gene. Both lines of SRC-3(d/d) mice exhibited growth retardation and low IGF-I levels, which was similar to that observed in SRC-3(-/-) mice. The line A SRC-3(d/d) mice showed normal viability, while line B SRC-3(d/d) mice showed partial lethality similar to SRC-3-/- mice, probably due to variable distributions of genetic background during breeding. These results demonstrate that the floxed SRC-3 mouse lines have been successfully established. These mice will be useful for investigating the cell type- and developmental stage-specific functions of SRC-3.

Entities:  

Keywords:  AIB1 Allele; SRC-3; knockout mice

Mesh:

Substances:

Year:  2008        PMID: 18690289      PMCID: PMC2491728          DOI: 10.7150/ijbs.4.202

Source DB:  PubMed          Journal:  Int J Biol Sci        ISSN: 1449-2288            Impact factor:   6.580


  29 in total

1.  Structure and chromosomal locations of mouse steroid receptor coactivator gene family.

Authors:  G Ning; V Jurecic; A Baldini; J Xu
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-09       Impact factor: 2.416

2.  AIB1 enhances estrogen-dependent induction of cyclin D1 expression.

Authors:  M D Planas-Silva; Y Shang; J L Donaher; M Brown; R A Weinberg
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

3.  AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.

Authors:  S L Anzick; J Kononen; R L Walker; D O Azorsa; M M Tanner; X Y Guan; G Sauter; O P Kallioniemi; J M Trent; P S Meltzer
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

4.  Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.

Authors:  M Lakso; J G Pichel; J R Gorman; B Sauer; Y Okamoto; E Lee; F W Alt; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

5.  Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells.

Authors:  H J List; K J Lauritsen; R Reiter; C Powers; A Wellstein; A T Riegel
Journal:  J Biol Chem       Date:  2001-04-27       Impact factor: 5.157

6.  SRC-3 is required for prostate cancer cell proliferation and survival.

Authors:  Hai-Jun Zhou; Jun Yan; Weiping Luo; Gustavo Ayala; Sue-Hwa Lin; Halime Erdem; Michael Ittmann; Sophia Y Tsai; Ming-Jer Tsai
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

7.  Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.

Authors:  Shao-Qing Kuang; Lan Liao; Shu Wang; Daniel Medina; Bert W O'Malley; Jianming Xu
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

8.  Steroid receptor coactivator-3 is required for inhibition of neointima formation by estrogen.

Authors:  Yuhui Yuan; Lan Liao; David A Tulis; Jianming Xu
Journal:  Circulation       Date:  2002-06-04       Impact factor: 29.690

9.  High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene.

Authors:  Maria I Torres-Arzayus; Jaime Font de Mora; Jing Yuan; Francisca Vazquez; Roderick Bronson; Montserrat Rue; William R Sellers; Myles Brown
Journal:  Cancer Cell       Date:  2004-09       Impact factor: 31.743

10.  Fibroblast growth factor receptor 3 is a negative regulator of bone growth.

Authors:  C Deng; A Wynshaw-Boris; F Zhou; A Kuo; P Leder
Journal:  Cell       Date:  1996-03-22       Impact factor: 41.582

View more
  8 in total

1.  The steroid receptor coactivator-3 is required for the development of castration-resistant prostate cancer.

Authors:  Jean C-Y Tien; Zhaoliang Liu; Lan Liao; Fen Wang; Yixiang Xu; Ye-Lin Wu; Niya Zhou; Michael Ittmann; Jianming Xu
Journal:  Cancer Res       Date:  2013-05-06       Impact factor: 12.701

Review 2.  Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family.

Authors:  Jianming Xu; Ray-Chang Wu; Bert W O'Malley
Journal:  Nat Rev Cancer       Date:  2009-09       Impact factor: 60.716

Review 3.  Steroid receptor coactivator-3 as a potential molecular target for cancer therapy.

Authors:  Jean Ching-Yi Tien; Jianming Xu
Journal:  Expert Opin Ther Targets       Date:  2012-08-27       Impact factor: 6.902

4.  The steroid receptor coactivator-3 is required for developing neuroendocrine tumor in the mouse prostate.

Authors:  Jean Ching-Yi Tien; Lan Liao; Yonghong Liu; Zhaoliang Liu; Dong-Kee Lee; Fen Wang; Jianming Xu
Journal:  Int J Biol Sci       Date:  2014-10-02       Impact factor: 6.580

5.  Knockout of SRC-1 and SRC-3 in Mice Decreases Cardiomyocyte Proliferation and Causes a Noncompaction Cardiomyopathy Phenotype.

Authors:  Xian Chen; Li Qin; Zhaoliang Liu; Lan Liao; James F Martin; Jianming Xu
Journal:  Int J Biol Sci       Date:  2015-07-15       Impact factor: 6.580

6.  The prostate basal cell (BC) heterogeneity and the p63-positive BC differentiation spectrum in mice.

Authors:  Dong-Kee Lee; Yonghong Liu; Lan Liao; Fen Wang; Jianming Xu
Journal:  Int J Biol Sci       Date:  2014-09-06       Impact factor: 6.580

7.  Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer.

Authors:  Daniel Richard Gomez; Lauren Averett Byers; Monique Nilsson; Lixia Diao; Jing Wang; Lerong Li; Pan Tong; Mia Hofstad; Babita Saigal; Ignacio Wistuba; Neda Kalhor; Stephen Swisher; Youhong Fan; Waun Ki Hong; Milind Suraokar; Carmen Behrens; Cesar Moran; John Victor Heymach
Journal:  Oncotarget       Date:  2018-01-30

8.  Steroid Receptor Coactivator 3 Regulates Synaptic Plasticity and Hippocampus-dependent Memory.

Authors:  Hai-Long Zhang; Bing Zhao; Pin Yang; Yin-Quan Du; Wei Han; Jianming Xu; Dong-Min Yin
Journal:  Neurosci Bull       Date:  2021-07-06       Impact factor: 5.203

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.